Gillian Divard

1.2k total citations
26 papers, 366 citations indexed

About

Gillian Divard is a scholar working on Transplantation, Surgery and Epidemiology. According to data from OpenAlex, Gillian Divard has authored 26 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Transplantation, 9 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Gillian Divard's work include Renal Transplantation Outcomes and Treatments (15 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Gillian Divard is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Gillian Divard collaborates with scholars based in France, United States and Switzerland. Gillian Divard's co-authors include Christophe Legendre, Olivier Aubert, Alexandre Loupy, Dany Anglicheau, Anne Scemla, Julien Zuber, Lucile Amrouche, Rébecca Sberro‐Soussan, Nathalie Chavarot and Carmen Lefaucheur and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Gillian Divard

23 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gillian Divard France	12	190	99	94	66	54	26	366
Rajan Kapoor United States	8	92 0.5×	80 0.8×	42 0.4×	36 0.5×	64 1.2×	27	294
Terence Kee Singapore	11	150 0.8×	108 1.1×	95 1.0×	73 1.1×	70 1.3×	54	401
E. Solà Spain	13	277 1.5×	151 1.5×	112 1.2×	41 0.6×	76 1.4×	50	477
Daniel Abramovicz Belgium	3	190 1.0×	113 1.1×	88 0.9×	43 0.7×	52 1.0×	4	372
Nauman Siddiqi Saudi Arabia	7	139 0.7×	82 0.8×	47 0.5×	145 2.2×	83 1.5×	9	465
William McKane United Kingdom	15	161 0.8×	176 1.8×	93 1.0×	23 0.3×	87 1.6×	30	481
Ashish Sharma India	11	118 0.6×	121 1.2×	90 1.0×	52 0.8×	50 0.9×	70	366
Hélène Longuet France	8	131 0.7×	51 0.5×	26 0.3×	57 0.9×	48 0.9×	25	276
Carme Facundo Spain	10	118 0.6×	71 0.7×	96 1.0×	25 0.4×	96 1.8×	32	311
Lúcio Requião‐Moura Brazil	12	137 0.7×	87 0.9×	77 0.8×	50 0.8×	40 0.7×	51	361

Countries citing papers authored by Gillian Divard

Since Specialization

Citations

This map shows the geographic impact of Gillian Divard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Divard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Divard more than expected).

Fields of papers citing papers by Gillian Divard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Divard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Divard. The network helps show where Gillian Divard may publish in the future.

Co-authorship network of co-authors of Gillian Divard

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Divard. A scholar is included among the top collaborators of Gillian Divard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Divard. Gillian Divard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chevalier, Mathieu F., Vincent Allain, Julien Gras, et al.. (2025). Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation. Science Advances. 11(10). eadt3499–eadt3499. 1 indexed citations

Demir, Zeynep, Marc Raynaud, Gillian Divard, et al.. (2025). Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts. Nature Communications. 16(1). 5692–5692. 1 indexed citations

Schnepf, Nathalie, Nadia Mahjoub, Aliénor Xhaard, et al.. (2024). Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients. Journal of Clinical Virology. 174. 105690–105690.

Divard, Gillian, et al.. (2024). BK Polyomavirus Infection in Kidney Transplantation: A Comprehensive Review of Current Challenges and Future Directions. International Journal of Molecular Sciences. 25(23). 12801–12801. 3 indexed citations

Gueguen, Juliette, Gillian Divard, Olivier Aubert, et al.. (2023). Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes. Nephrology Dialysis Transplantation. 39(1). 64–73.

Klein, Amanda, Alexandre Loupy, Mark D. Stegall, et al.. (2023). Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes. American Journal of Transplantation. 23(10). 1496–1506. 14 indexed citations

Klein, Amanda, Alexandre Loupy, Mark D. Stegall, et al.. (2023). Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes. Transplant International. 36. 11951–11951. 8 indexed citations

Hogan, Julien, Gillian Divard, Olivier Aubert, et al.. (2023). Validation of a prediction system for risk of kidney allograft failure in pediatric kidney transplant recipients: An international observational study. American Journal of Transplantation. 23(10). 1561–1569. 4 indexed citations

Divard, Gillian, Marc Raynaud, Vasishta Tatapudi, et al.. (2022). Comparison of artificial intelligence and human-based prediction and stratification of the risk of long-term kidney allograft failure. SHILAP Revista de lepidopterología. 2(1). 150–150. 16 indexed citations

10.

Vaulet, Thibaut, Gillian Divard, Olivier Thaunat, et al.. (2022). Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies. Journal of the American Society of Nephrology. 33(11). 2026–2039. 17 indexed citations

11.

Aubert, Olivier, Gillian Divard, Julio Pascual, et al.. (2021). Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study. BMJ Open. 11(10). e052138–e052138. 24 indexed citations

12.

Divard, Gillian & Valentin Goutaudier. (2021). Global Perspective on Kidney Transplantation: France. Kidney360. 2(10). 1637–1640. 5 indexed citations

13.

Chavarot, Nathalie, Antoine Morel, Marianne Leruez‐Ville, et al.. (2021). Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. American Journal of Transplantation. 21(12). 4043–4051. 70 indexed citations

14.

Vaulet, Thibaut, Gillian Divard, Olivier Thaunat, et al.. (2021). Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering. Journal of the American Society of Nephrology. 32(5). 1084–1096. 25 indexed citations

15.

Reese, Peter P., Olivier Aubert, Maarten Naesens, et al.. (2020). Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. Journal of the American Society of Nephrology. 32(2). 397–409. 49 indexed citations

16.

Chavarot, Nathalie, Gillian Divard, Anne Scemla, et al.. (2020). Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept. American Journal of Transplantation. 21(7). 2448–2458. 39 indexed citations

17.

Bello, Arnaud Del, Gillian Divard, Julie Bellière, et al.. (2019). Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation. Clinical Transplantation. 33(10). e13681–e13681. 5 indexed citations

18.

David, C., Gillian Divard, Rachid Abbas, et al.. (2019). Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. Clinica Chimica Acta. 493. S84–S84. 4 indexed citations

19.

Divard, Gillian, Rachid Abbas, Camille Chenevier‐Gobeaux, et al.. (2017). High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study. Arthritis Research & Therapy. 19(1). 132–132. 25 indexed citations

20.

Bagnis, Corinne Isnard, L. Richard, Gillian Divard, et al.. (2016). Facteurs de risque de maladie rénale chronique dans la cirrhose virale compensée (ANRS CO12 cirvir cohorte prospective). Néphrologie & Thérapeutique. 12(5). 375–376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact